Table 1.
Prevalence of anemia before initiation of ART among HIV-infected children attending ART in Hiwot Fana Specialized University Hospital, Harar, eastern Ethiopa, 2011
| Variables | Anemic, N (%) | Non-anemic, N (%) | P-value |
|---|---|---|---|
| Age (years) | |||
| Preschool (<7) | 36 (35) | 14 (13.6) | <0.01 |
| School (≥7) | 20 (19.4) | 33 (32.0) | |
| Sex | |||
| Male | 30 (29.1) | 17 (16.5) | 0.07 |
| Female | 26 (25.2) | 30 (29.2) | |
| Residence | |||
| Urban | 51 (49.5) | 44 (42.7) | 0.63 |
| Rural | 5 (4.9) | 3 (2.9) | |
| WHO clinical stage | |||
| 1 and 2 | 23 (23.2) | 15 (15.2) | 0.35 |
| 3 and 4 | 31 (31.3) | 30 (30.3) | |
| Tuberculosis infection | |||
| Positive | 8 (7.8) | 7 (6.8) | 0.51 |
| Negative | 49 (47.6) | 39 (37.9) | |
| Cotrimoxazole treatment | |||
| Yes | 55 (53.4) | 47 (45.6) | 1.00* |
| No | 1 (1.0) | 0 (0%) | |
| Immunosuppression | |||
| No evidence | 4 (4.1) | 7 (7.2) | 0.26 |
| Moderate | 11 (11.3) | 12 (12.4) | |
| Severe | 38 (25.8) | 25 (39.2) | |
Note:
*
Fisher’s exact test result.
Abbreviations: ART, antiretroviral therapy; HIV, human immunodeficiency virus; N, number of patients; WHO, World Health Organization.